| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.27B | 1.15B | 1.06B | 951.12M | 864.50M | 764.77M |
| Gross Profit | 415.24M | 375.02M | 339.88M | 299.74M | 269.85M | 226.24M |
| EBITDA | 135.36M | 120.61M | 106.56M | 83.14M | 80.70M | 57.18M |
| Net Income | 82.97M | 73.60M | 62.52M | 46.02M | 45.13M | 33.13M |
Balance Sheet | ||||||
| Total Assets | 1.41B | 1.41B | 1.02B | 937.99M | 947.59M | 892.58M |
| Cash, Cash Equivalents and Short-Term Investments | 91.18M | 98.91M | 64.79M | 79.96M | 168.90M | 145.08M |
| Total Debt | 222.25M | 273.13M | 175.18M | 178.05M | 263.55M | 239.67M |
| Total Liabilities | 387.08M | 442.14M | 317.73M | 304.45M | 373.24M | 373.91M |
| Stockholders Equity | 1.02B | 970.49M | 706.69M | 633.54M | 574.34M | 518.68M |
Cash Flow | ||||||
| Free Cash Flow | 96.79M | 110.38M | 102.79M | 96.81M | 34.84M | 102.58M |
| Operating Cash Flow | 100.42M | 116.43M | 112.25M | 105.11M | 39.49M | 109.41M |
| Investing Cash Flow | -356.09M | -354.61M | -119.24M | -106.59M | -42.02M | -214.24M |
| Financing Cash Flow | 173.54M | 272.30M | -8.18M | -87.45M | 26.34M | 138.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $2.22B | 24.44 | 8.58% | ― | 18.77% | 6.88% | |
73 Outperform | $1.94B | 18.63 | 10.65% | 1.97% | 25.19% | 13.44% | |
69 Neutral | $873.73M | 32.33 | 10.87% | ― | 29.89% | 10.33% | |
61 Neutral | $1.67B | 132.65 | 1.29% | ― | 68.17% | -85.23% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | $312.39M | ― | -73.31% | ― | 5.21% | 5.21% |
On November 3, 2025, Addus HomeCare Corporation announced its financial results for the third quarter of 2025, showing a 25.0% increase in net service revenues to $362.3 million and a 31.6% rise in adjusted EBITDA to $45.1 million compared to the same period in 2024. The company completed the acquisition of Del Cielo Home Care Services on October 1, 2025, expanding its personal care operations in Texas, which is expected to positively impact its financial results and market coverage.
The most recent analyst rating on (ADUS) stock is a Buy with a $132.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.
On August 4, 2025, Addus HealthCare, a subsidiary of Addus HomeCare Corporation, announced the appointment of Heather Dixon as President and Chief Operating Officer, effective September 15, 2025. Dixon, who brings extensive experience in healthcare leadership, succeeds W. Bradley Bickham, who will transition to an advisory role until his retirement in March 2026. Dixon’s appointment is expected to bolster Addus’s operational excellence and support its growth strategy. Her previous roles include CFO positions at Acadia Healthcare and Everside Health, and she has served as an independent director for Addus since March 2023.
The most recent analyst rating on (ADUS) stock is a Buy with a $147.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.
Addus HomeCare Corporation is a provider of home care services, primarily offering personal care, hospice, and home health services across 23 states in the United States. The company focuses on assisting individuals who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill, and disabled.
The recent earnings call for Addus HomeCare Corporation painted a generally positive picture, with strong revenue growth and strategic acquisitions taking center stage. Despite some challenges, such as clinical hiring difficulties and concerns over CMS’s proposed payment changes, the overall sentiment leaned towards optimism, with the positive developments slightly outweighing the negatives.